Company Overview of Cellegy Australia Pty. Ltd.
Cellegy Australia Pty., Ltd. provides a therapeutic treatment for anal fissures. Its Rectogesic ointment contains glyceryl trinitrate in a base of liquid paraffin, soft yellow paraffin, lanolin, and ethanol. This product is used for the treatment and relief of symptoms of anal fissure. The company was formerly known as Quay Pharmaceuticals Pty., Ltd. As a result of Quay Pharmaceuticals acquisition by Cellegy Pharmaceuticals, Inc. in June 2000, its name was changed to Cellegy Australia Pty., Ltd. The company is based in Edgecliff, Australia. As of April 11, 2006, Cellegy Australia Pty., Ltd. is a subsidiary of Epsilon Pharmaceuticals.
203-233 New South Head Road
Level 5, Edgecliff Centre
Edgecliff, NSW 2027
Key Executives for Cellegy Australia Pty. Ltd.
Cellegy Australia Pty. Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Alchemia Oncology Pty Limited||Asia|
|De Motu Cordis Pty. Ltd.||Asia|
|A.C.N. 108 768 896 PTY Ltd||Asia|
|Merial Australia Pty. Ltd.||Asia|
|Novartis Consumer Health Australasia Pty. Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Cellegy Australia Pty. Ltd., please visit www.rectogesic.com/index2.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.